Episode Details
Back to EpisodesAI Drug Discovery Breakthrough + Insilico Phase 2 Success & 31% Better Cancer Detection
Published 6 months, 1 week ago
Description
Insilico Medicine announces its AI-designed anti-fibrotic drug has entered Phase 2 clinical trials in just 18 months — far faster than the industry average.
We also cover:
• Recursion Pharmaceuticals reporting 12 new clinical-stage drug candidates generated by its AI platform in the past year
• Pfizer and Tempus partnering to use AI for matching cancer patients with personalized clinical trials
• A new NEJM study showing AI-assisted diagnostic tools improved early cancer detection rates by 31% in routine screenings